{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:07:45Z","timestamp":1789679265008,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Postoperative hypotony following PRESERFLO MicroShunt (PMS) implantation is a frequent cause of complications such as choroidal detachment and hypotony maculopathy. This study aims at evaluating the impact of intraluminal stenting of the PMS during the early postoperative period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed the data of 97 patients who underwent PMS implantation with intraoperative placement of a Nylon 10\u20130 suture as intraluminal stent (PStent) and compared the outcomes to those of an existing database of the traditional MicroShunt implantation technique (PTrad, <jats:italic>n<\/jats:italic>\u2009=\u2009120). The primary outcome measure was the intraocular pressure (IOP) at one week postoperatively. As a secondary outcome measure, adverse hypotony, defined as an IOP\u2009\u2264\u20095\u00a0mmHg with significant choroidal effusion and\/or anterior chamber shallowing or the presence of macular folds was also assessed. Additionally, the time to stent removal and the IOP one week after stent removal were reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Preoperative median IOP was 25.0 (20.5\u201330.3) mmHg in PStent and 25.0 (19.3\u201332.0) mmHg in PTrad (<jats:italic>p<\/jats:italic>\u2009=\u20090.62). One week after surgery, the median IOP dropped to 10.0 (8.0\u201313.0) mmHg in PStent and 7.0 (5.0\u20139.0) in PTrad (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). At one month, the IOP was 12.0 (10.0\u201314.0) mmHg in PStent and 10.0 (8.0\u201311.0) mmHg in PTrad (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). After 3\u00a0months, both groups showed similar median IOP levels of 11.0 (8.0\u201313.5) mmHg and 10.0 (9.75\u201313.0) mmHg in PStent and PTrad, respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.66). The presence of adverse hypotony was significantly lower in PStent compared to PTrad (6.2% vs 15.8%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In PStent the stent was removed after 30.0 (21.0\u201342.5) days. One week after stent removal the mean IOP drop was 6.1\u2009\u00b1\u20090.5\u00a0mmHg (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the early follow-up period, intraluminal stenting of the PMS appears to be safe and effective in controlling the IOP while reducing early postoperative hypotony. Surgical success is not compromised by stent placement. Based on our data, it is recommended to remove the suture two to six weeks after surgery for most patients with uncomplicated postoperative clinical findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-024-06567-x","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:37:02Z","timestamp":1720237022000},"page":"3925-3932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony"],"prefix":"10.1007","volume":"262","author":[{"given":"Raoul","family":"Verma-Fuehring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Dakroub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bamousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunda","family":"Kann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Hillenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-5875","authenticated-orcid":false,"given":"Daniel","family":"Kampik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"6567_CR1","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","volume":"128","author":"ND Baker","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK et al (2021) Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-Year randomized. Multicenter Study Ophthalmol 128:1710\u20131721. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.023","journal-title":"Multicenter Study Ophthalmol"},{"key":"6567_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2147\/OPTH.S46375","volume":"7","author":"A Haga","year":"2013","unstructured":"Haga A, Inatani M, Shobayashi K, Kojima S, Inoue T, Tanihara H (2013) Risk factors for choroidal detachment after trabeculectomy with mitomycin C. Clin Ophthalmol 7:1417\u20131421. https:\/\/doi.org\/10.2147\/OPTH.S46375","journal-title":"Clin Ophthalmol"},{"key":"6567_CR3","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s10792-022-02342-1","volume":"42","author":"NY Ercalik","year":"2022","unstructured":"Ercalik NY, Tekcan H, Mangan MS, Ozcelik Kose A, Imamoglu S (2022) Analysis of risk factors and ocular hypotony characteristics in choroidal detachment after penetrating glaucoma surgery. Int Ophthalmol 42:3431\u20133440. https:\/\/doi.org\/10.1007\/s10792-022-02342-1","journal-title":"Int Ophthalmol"},{"key":"6567_CR4","unstructured":"Okonkwo ON, Tripathy K (2023) Ocular hypotony. StatPearls Publishing. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK582144\/. Accessed 03 Jan 2024"},{"key":"6567_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/s0002-9394(14)74481-2","volume":"114","author":"RL Stamper","year":"1992","unstructured":"Stamper RL, McMenemy MG, Lieberman MF (1992) Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol 114:544\u2013553. https:\/\/doi.org\/10.1016\/s0002-9394(14)74481-2","journal-title":"Am J Ophthalmol"},{"key":"6567_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40123-015-0037-z","volume":"4","author":"M Thomas","year":"2015","unstructured":"Thomas M, Vajaranant TS, Aref AA (2015) Hypotony Maculopathy: Clinical Presentation and Therapeutic Methods. Ophthalmol Ther 4:79\u201388. https:\/\/doi.org\/10.1007\/s40123-015-0037-z","journal-title":"Ophthalmol Ther"},{"key":"6567_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","volume":"30","author":"JF Batlle","year":"2021","unstructured":"Batlle JF, Corona A, Albuquerque R (2021) Long-term results of the PRESERFLO MicroShunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma 30:281\u2013286. https:\/\/doi.org\/10.1097\/IJG.0000000000001734","journal-title":"J Glaucoma"},{"key":"6567_CR8","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s10792-023-02664-8","volume":"43","author":"JN L\u00fcke","year":"2023","unstructured":"L\u00fcke JN, Reinking N, Dietlein TS, Haendel A, Enders P, Lappas A (2023) Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony. Int Ophthalmol 43:2643\u20132651. https:\/\/doi.org\/10.1007\/s10792-023-02664-8","journal-title":"Int Ophthalmol"},{"key":"6567_CR9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/jcm12041677","volume":"12","author":"E Lupardi","year":"2023","unstructured":"Lupardi E, Laffi GL, Moramarco A, Barboni P, Fontana L (2023) Systematic Preserflo MicroShunt Intraluminal Stenting for Hypotony Prevention in Highly Myopic Patients: A Comparative Study. J Clin Med Res 12:1677. https:\/\/doi.org\/10.3390\/jcm12041677","journal-title":"J Clin Med Res"},{"key":"6567_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0161-6420(93)31688-x","volume":"100","author":"MB Sherwood","year":"1993","unstructured":"Sherwood MB, Smith MF (1993) Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology 100:85\u201390. https:\/\/doi.org\/10.1016\/s0161-6420(93)31688-x","journal-title":"Ophthalmology"},{"key":"6567_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/IJG.0000000000000135","volume":"25","author":"E Sharkawi","year":"2016","unstructured":"Sharkawi E, Artes PH, Oleszczuk JD, Bela C, Achache F, Barton K et al (2016) Systematic Occlusion of Shunts: Control of Early Postoperative IOP and Hypotony-related Complications Following Glaucoma Shunt Surgery. J Glaucoma 25:54\u201361. https:\/\/doi.org\/10.1097\/IJG.0000000000000135","journal-title":"J Glaucoma"},{"key":"6567_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/IJG.0000000000002013","volume":"31","author":"DS Grover","year":"2022","unstructured":"Grover DS, Kahook MY, Seibold LK, Singh IP, Ansari H, Butler MR et al (2022) Clinical Outcomes of Ahmed ClearPath Implantation in Glaucomatous Eyes: A Novel Valveless Glaucoma Drainage Device. J Glaucoma 31:335\u2013339. https:\/\/doi.org\/10.1097\/IJG.0000000000002013","journal-title":"J Glaucoma"},{"key":"6567_CR13","unstructured":"Shaarawy TM, Sherwood MB, Grehn F (2018) Guidelines on design & reporting glaucoma trials. In: World glaucoma association. Available: https:\/\/wga.one\/wpfd_file\/guidelines-on-design-reporting-glaucoma-trials\/.\u00a0Accessed 03 Jan 2024"},{"key":"6567_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0002-9394(98)00436-x","volume":"127","author":"CB Toris","year":"1999","unstructured":"Toris CB, Yablonski ME, Wang YL, Camras CB (1999) Aqueous humor dynamics in the aging human eye. Am J Ophthalmol 127:407\u2013412. https:\/\/doi.org\/10.1016\/s0002-9394(98)00436-x","journal-title":"Am J Ophthalmol"},{"key":"6567_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0531-5565(91)90058-t","volume":"26","author":"SA Bruce","year":"1991","unstructured":"Bruce SA, Deamond SF (1991) Longitudinal study of in vivo wound repair and in vitro cellular senescence of dermal fibroblasts. Exp Gerontol 26:17\u201327. https:\/\/doi.org\/10.1016\/0531-5565(91)90058-t","journal-title":"Exp Gerontol"},{"key":"6567_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0733-8635(18)30227-4","volume":"11","author":"AD Gerstein","year":"1993","unstructured":"Gerstein AD, Phillips TJ, Rogers GS, Gilchrest BA (1993) Wound healing and aging. Dermatol Clin 11:749\u2013757. https:\/\/doi.org\/10.1016\/S0733-8635(18)30227-4","journal-title":"Dermatol Clin"},{"key":"6567_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00055735-199604000-00013","volume":"7","author":"H Mietz","year":"1996","unstructured":"Mietz H (1996) The toxicology of mitomycin C on the ciliary body. Curr Opin Ophthalmol 7:72\u201379. https:\/\/doi.org\/10.1097\/00055735-199604000-00013","journal-title":"Curr Opin Ophthalmol"},{"key":"6567_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E et al (2017) The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater 105:211\u2013221. https:\/\/doi.org\/10.1002\/jbm.b.33525","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"6567_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.10.13.26","volume":"10","author":"M Ibarz Barber\u00e1","year":"2021","unstructured":"Ibarz Barber\u00e1 M, Hern\u00e1ndez-Verdejo JL, Bragard J, Burguete J, Fern\u00e1ndez LM, Rivero PT et al (2021) Evaluation of the Ultrastructural and In Vitro Flow Properties of the PRESERFLO MicroShunt. Transl Vis Sci Technol 10:26. https:\/\/doi.org\/10.1167\/tvst.10.13.26","journal-title":"Transl Vis Sci Technol"},{"key":"6567_CR20","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.3390\/jcm12237266","volume":"12","author":"A Masdipa","year":"2023","unstructured":"Masdipa A, Kaidzu S, Tanito M (2023) Exploring the pressure characteristics of the PRESERFLO microshunt in in vitro studies and effects of sclera on device performance. J Clin Med Res 12:7266. https:\/\/doi.org\/10.3390\/jcm12237266","journal-title":"J Clin Med Res"},{"key":"6567_CR21","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s40123-022-00529-4","volume":"11","author":"AP Khawaja","year":"2022","unstructured":"Khawaja AP, Stalmans I, Aptel F, Barton K, Beckers H, Klink T et al (2022) Expert consensus on the use of the PRESERFLOTM MicroShunt device in the treatment of glaucoma: A Modified Delphi Panel. Ophthalmol Ther 11:1743\u20131766. https:\/\/doi.org\/10.1007\/s40123-022-00529-4","journal-title":"Ophthalmol Ther"},{"key":"6567_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E, Ahmed IIK (2020) Intermediate outcomes of a novel standalone Ab Externo SIBS MICROSHUNT With Mitomycin C. Am J Ophthalmol 215:141\u2013153. https:\/\/doi.org\/10.1016\/j.ajo.2020.02.020","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06567-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06567-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06567-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T09:02:17Z","timestamp":1732957337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06567-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6567"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06567-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Institutional Review Board (IRB) of the University of W\u00fcrzburg. The study adhered to the principles stated in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In Germany informed consent is not required for retrospective studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}